article · Scientific Reports
Cardiovascular disease (CVD) continues to be a major global health concern, underscoring the need for advancements in medical care. The use of electrocardiograms (ECGs) is crucial for diagnosing cardiac conditions. However, the reliance on professional expertise for manual ECG interpretation poses challenges for expanding accessible healthcare, particularly in community hospitals. To address this, there is a growing interest in leveraging automated and AI-driven ECG analysis systems, which can enhance diagnostic accuracy and efficiency, making quality cardiac care more accessible to a broader population. In this study, we implemented a novel deep two-dimensional convolutional neural network (2D-CNN) on a dataset of PTB-XL for cardiac disorder detection. The studies were performed on 2, 5, and 23 classes of cardiovascular diseases. The our network in classifying healthy/sick patients achived an AUC of 95% and an average accuracy of 87.85%. In 5-classes classification, our model achieved an AUC of 93.46% with an average accuracy of 89.87%. In a more complex scenario involving classification into 23 different classes, the model achieved an AUC of 92.18% and an accuracy of 96.88%. According to the experimental results, our model obtained the best classification result compared to the other methods based on the same public dataset. This indicates that our method can aid healthcare professionals in the clinical analysis of ECGs, offering valuable assistance in diagnosing CVD and contributing to the advancement of computer-aided diagnosis technology.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1038/s41598-024-72382-3
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.